T2	AdverseReaction 184 189	death
T3	AdverseReaction 194 232	cerebrovascular-related adverse events
T4	AdverseReaction 244 250	stroke
T5	AdverseReaction 268 283	QT prolongation
T6	AdverseReaction 285 305	Prolongs QT interval
T7	AdverseReaction 333 343	arrhythmia
T8	Factor 310 313	may
T9	AdverseReaction 348 360	sudden death
T10	AdverseReaction 738 768	Neuroleptic Malignant Syndrome
T11	AdverseReaction 854 872	Tardive dyskinesia
T12	AdverseReaction 932 945	Hyperglycemia
T13	AdverseReaction 950 967	diabetes mellitus
T14	AdverseReaction 1150 1162	Dyslipidemia
T15	AdverseReaction 1273 1284	Weight Gain
T17	AdverseReaction 1458 1472;1489 1493	cardiovascular risk
T18	AdverseReaction 1473 1488;1489 1493	cerebrovascular risk
T19	AdverseReaction 1527 1540	hyperglycemia
T20	AdverseReaction 1542 1554	dyslipidemia
T21	AdverseReaction 1560 1571	weight gain
T22	AdverseReaction 1589 1597	Seizures
T23	AdverseReaction 1718 1741	Orthostatic hypotension
T24	AdverseReaction 1820 1830	Leukopenia
T25	AdverseReaction 1832 1843	Neutropenia
T26	AdverseReaction 1849 1864	Agranulocytosis
T27	AdverseReaction 2238 2245	Suicide
T28	AdverseReaction 2305 2313	Priapism
T29	AdverseReaction 2409 2418;2429 2439	cognitive impairment
T30	AdverseReaction 2423 2439	motor impairment
T31	Factor 2395 2404	Potential
T34	AdverseReaction 2810 2815	death
T35	AdverseReaction 3167 3197	cerebrovascular adverse events
T36	AdverseReaction 3199 3224	cerebrovascular accidents
T37	AdverseReaction 3229 3255	transient ischemic attacks
T38	AdverseReaction 3267 3277	fatalities
T39	AdverseReaction 3589 3605	QTc prolongation
T41	AdverseReaction 3969 3982	QTcF increase
T43	AdverseReaction 4031 4049	torsade de pointes
T44	Negation 4019 4021	No
T45	AdverseReaction 4066 4085	cardiac arrhythmias
T46	Severity 4059 4065	severe
T53	AdverseReaction 6339 6369	Neuroleptic Malignant Syndrome
T54	AdverseReaction 6371 6374	NMS
T55	AdverseReaction 6503 6515	hyperpyrexia
T56	AdverseReaction 6517 6532	muscle rigidity
T57	AdverseReaction 6534 6555	altered mental status
T58	AdverseReaction 6567 6582	catatonic signs
T59	AdverseReaction 6600 6621	autonomic instability
T60	AdverseReaction 6623 6632;6633 6638	irregular pulse
T61	AdverseReaction 6623 6632;6642 6656	irregular blood pressure
T62	AdverseReaction 6658 6669	tachycardia
T63	AdverseReaction 6671 6682	diaphoresis
T64	AdverseReaction 6688 6707	cardiac dysrhythmia
T65	AdverseReaction 6739 6770	elevated creatine phosphokinase
T66	AdverseReaction 6772 6785	myoglobinuria
T67	AdverseReaction 6787 6801	rhabdomyolysis
T68	AdverseReaction 6808 6827	acute renal failure
T69	AdverseReaction 8046 8064	Tardive dyskinesia
T71	AdverseReaction 8119 8152	involuntary, dyskinetic movements
T80	AdverseReaction 10366 10389;10406 10410	increase cardiovascular risk
T82	AdverseReaction 10366 10374;10390 10410	increase cerebrovascular risk
T83	AdverseReaction 10444 10457	hyperglycemia
T84	AdverseReaction 10459 10471	dyslipidemia
T85	AdverseReaction 10477 10493	body weight gain
T86	AdverseReaction 10736 10749	Hyperglycemia
T87	AdverseReaction 10793 10805	ketoacidosis
T88	Severity 10765 10772	extreme
T89	AdverseReaction 10809 10826	hyperosmolar coma
T90	AdverseReaction 10830 10835	death
T92	AdverseReaction 11438 11474	hyperglycemia-related adverse events
T94	AdverseReaction 13745 13778	Undesirable alterations in lipids
T95	AdverseReaction 16234 16245	Weight gain
T101	AdverseReaction 17308 17316	seizures
T102	AdverseReaction 17786 17809	orthostatic hypotension
T103	Factor 17775 17778	can
T104	AdverseReaction 17826 17835	dizziness
T105	AdverseReaction 17837 17848	tachycardia
T106	AdverseReaction 17854 17861	syncope
T107	AdverseReaction 18036 18043	syncope
T108	AdverseReaction 18146 18169	Orthostatic hypotension
T109	AdverseReaction 18965 18975	leukopenia
T110	AdverseReaction 18976 18987	neutropenia
T111	AdverseReaction 19051 19066	Agranulocytosis
T112	AdverseReaction 19145 19155	leukopenia
T113	AdverseReaction 19156 19167	neutropenia
T114	AdverseReaction 19992 20017	elevates prolactin levels
T115	AdverseReaction 20024 20042	Hyperprolactinemia
T116	AdverseReaction 20149 20178	inhibit reproductive function
T117	AdverseReaction 20249 20261	Galactorrhea
T118	AdverseReaction 20263 20273	amenorrhea
T119	AdverseReaction 20275 20287	gynecomastia
T120	AdverseReaction 20293 20302	impotence
T121	AdverseReaction 20358 20390	Long-standing hyperprolactinemia
T122	Factor 20425 20428	may
T123	AdverseReaction 20437 20459	decreased bone density
T124	AdverseReaction 20800 20828	increases in serum prolactin
T125	AdverseReaction 20760 20795	Mammary gland proliferative changes
T126	Animal 20842 20846	mice
T127	Animal 20851 20855	rats
T128	AdverseReaction 21440 21472	elevated plasma prolactin levels
T129	AdverseReaction 21275 21298;21345 21353	plasma prolactin levels increase
T130	Severity 21357 21366	2.6 ng/mL
T131	AdverseReaction 21632 21651	prolactin elevation
T132	AdverseReaction 21852 21864	gynecomastia
T133	AdverseReaction 21952 21964	galactorrhea
T134	AdverseReaction 22121 22185	Disruption of the body's ability to reduce core body temperature
T135	DrugClass 22209 22229	antipsychotic agents
T136	AdverseReaction 22579 22601	Esophageal dysmotility
T137	AdverseReaction 22606 22616	aspiration
T138	DrugClass 22643 22661	antipsychotic drug
T140	AdverseReaction 23322 23330	priapism
T141	DrugClass 23381 23425	Drugs with alpha-adrenergic blocking effects
T142	AdverseReaction 23455 23463	priapism
T143	AdverseReaction 23515 23523	priapism
T144	Severity 23508 23514	Severe
T145	AdverseReaction 23681 23696	impair judgment
T146	AdverseReaction 23681 23687;23698 23706	impair thinking
T147	AdverseReaction 23681 23687;23710 23722	impair motor skills
T148	AdverseReaction 23766 23776	somnolence
T149	AdverseReaction 23788 23796	sedation
T150	DrugClass 127 155	atypical antipsychotic drugs
T151	DrugClass 1367 1395	Atypical antipsychotic drugs
T152	AdverseReaction 1743 1752	Dizziness
T153	AdverseReaction 1754 1765	tachycardia
T154	AdverseReaction 1771 1778	syncope
T155	Factor 1779 1782	can
T156	DrugClass 1889 1903	antipsychotics
T32	DrugClass 2753 2781	atypical antipsychotic drugs
T48	DrugClass 8197 8216	antipsychotic drugs
T49	DrugClass 10284 10312	Atypical antipsychotic drugs
T50	DrugClass 11504 11527	atypical antipsychotics
T51	DrugClass 13823 13846	atypical antipsychotics
T52	DrugClass 16269 16291	atypical antipsychotic
T72	AdverseReaction 16523 16542	gain in body weight
T73	DrugClass 19029 19049	antipsychotic agents
T74	AdverseReaction 19078 19083	fatal
T75	AdverseReaction 20088 20128	reduced pituitary gonadotropin secretion
T76	AdverseReaction 20047 20073	suppress hypothalamic GnRH
T77	Factor 20043 20046	may
T78	AdverseReaction 20412 20424	hypogonadism
T91	DrugClass 20327 20356	prolactin-elevating compounds
T96	Severity 21615 21628	modest levels
T97	AdverseReaction 21672 21692	prolactin elevations
T98	Severity 21664 21671	greater
T99	DrugClass 21712 21738	other antipsychotic agents
T100	Factor 23668 23677	potential
T40	Factor 20145 20148	may
T42	AdverseReaction 20182 20214	impairing gonadalsteroidogenesis
T81	AdverseReaction 1348 1365	Metabolic Changes
T139	AdverseReaction 1501 1518	metabolic changes
T157	Factor 6727 6730	may
E2	AdverseReaction:T2 Hypothetical2:E150
E3	AdverseReaction:T3 Hypothetical:E150
E4	AdverseReaction:T4 Hypothetical:E150
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7 Hypothetical:E8
E8	Factor:T8
E9	AdverseReaction:T9 Hypothetical:E8
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E17	AdverseReaction:T17 Hypothetical2:E151
E18	AdverseReaction:T18 Hypothetical2:E151
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24 Hypothetical:E156
E25	AdverseReaction:T25 Hypothetical:E156
E26	AdverseReaction:T26 Hypothetical:E156
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29 Hypothetical:E31
E30	AdverseReaction:T30 Hypothetical:E31
E31	Factor:T31
E34	AdverseReaction:T34 Hypothetical2:E32
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37
E38	AdverseReaction:T38
E39	AdverseReaction:T39
E41	AdverseReaction:T41
E43	AdverseReaction:T43 Negated:E44
E44	Negation:T44
E45	AdverseReaction:T45 Effect:E46 Negated:E44
E46	Severity:T46
E53	AdverseReaction:T53
E54	AdverseReaction:T54
E55	AdverseReaction:T55
E56	AdverseReaction:T56
E57	AdverseReaction:T57
E58	AdverseReaction:T58
E59	AdverseReaction:T59
E60	AdverseReaction:T60
E61	AdverseReaction:T61
E62	AdverseReaction:T62
E63	AdverseReaction:T63
E64	AdverseReaction:T64
E65	AdverseReaction:T65 Hypothetical:E158
E66	AdverseReaction:T66 Hypothetical:E158
E67	AdverseReaction:T67 Hypothetical:E158
E68	AdverseReaction:T68 Hypothetical:E158
E69	AdverseReaction:T69
E71	AdverseReaction:T71 Hypothetical2:E48
E80	AdverseReaction:T80 Hypothetical2:E49
E82	AdverseReaction:T82 Hypothetical:E49
E83	AdverseReaction:T83
E84	AdverseReaction:T84
E85	AdverseReaction:T85
E86	AdverseReaction:T86 Effect:E88
E87	AdverseReaction:T87
E88	Severity:T88
E89	AdverseReaction:T89
E90	AdverseReaction:T90
E92	AdverseReaction:T92 Hypothetical2:E51
E94	AdverseReaction:T94 Hypothetical:E52
E95	AdverseReaction:T95 Hypothetical:E72
E101	AdverseReaction:T101
E102	AdverseReaction:T102 Hypothetical:E103
E103	Factor:T103
E104	AdverseReaction:T104 Hypothetical:E103
E105	AdverseReaction:T105 Hypothetical:E103
E106	AdverseReaction:T106 Hypothetical:E103
E107	AdverseReaction:T107
E108	AdverseReaction:T108
E109	AdverseReaction:T109 Hypothetical:E74
E110	AdverseReaction:T110 Hypothetical:E74
E111	AdverseReaction:T111
E112	AdverseReaction:T112
E113	AdverseReaction:T113
E114	AdverseReaction:T114
E115	AdverseReaction:T115
E116	AdverseReaction:T116 Hypothetical:E40
E117	AdverseReaction:T117 Hypothetical:E96
E118	AdverseReaction:T118 Hypothetical:E96
E119	AdverseReaction:T119 Hypothetical:E96
E120	AdverseReaction:T120 Hypothetical:E96
E121	AdverseReaction:T121
E122	Factor:T122
E123	AdverseReaction:T123 Hypothetical:E122
E124	AdverseReaction:T124 Hypothetical:E126 Hypothetical2:E127
E125	AdverseReaction:T125 Hypothetical:E127 Hypothetical2:E126
E126	Animal:T126
E127	Animal:T127
E128	AdverseReaction:T128
E129	AdverseReaction:T129 Effect:E130
E130	Severity:T130
E131	AdverseReaction:T131 Effect:E97
E132	AdverseReaction:T132
E133	AdverseReaction:T133
E134	AdverseReaction:T134 Hypothetical:E135
E135	DrugClass:T135
E136	AdverseReaction:T136 Hypothetical:E138
E137	AdverseReaction:T137 Hypothetical:E138
E138	DrugClass:T138
E140	AdverseReaction:T140
E141	DrugClass:T141
E142	AdverseReaction:T142 Hypothetical:E141
E143	AdverseReaction:T143 Effect:E144
E144	Severity:T144
E145	AdverseReaction:T145 Hypothetical:E139
E146	AdverseReaction:T146 Hypothetical:E139
E147	AdverseReaction:T147 Hypothetical:E139
E148	AdverseReaction:T148
E149	AdverseReaction:T149
E150	DrugClass:T150
E151	DrugClass:T151
E152	AdverseReaction:T152 Hypothetical:E155
E153	AdverseReaction:T153 Hypothetical:E155
E154	AdverseReaction:T154 Hypothetical:E155
E155	Factor:T155
E156	DrugClass:T156
E32	DrugClass:T32
E48	DrugClass:T48
E49	DrugClass:T49
E50	AdverseReaction:T86
E51	DrugClass:T50
E52	DrugClass:T51
E72	DrugClass:T52
E73	AdverseReaction:T72
E74	DrugClass:T73
E75	AdverseReaction:T74
E76	AdverseReaction:T75
E77	AdverseReaction:T76 Hypothetical:E78
E78	Factor:T77
E91	AdverseReaction:T78
E96	DrugClass:T91
E97	Severity:T96
E98	AdverseReaction:T97 Effect:E99 Hypothetical:E100
E99	Severity:T98
E100	DrugClass:T99
E139	Factor:T100
E40	Factor:T40
E42	AdverseReaction:T42
E81	AdverseReaction:T81
E157	AdverseReaction:T139
E158	Factor:T157
A1	CUI E2 C1306577
A2	UMLS-Preferred-Name E2 Death (finding)
A3	MEDDRA-PT E2 Death
A4	MEDDRA-PT-ID E2 10011906
A5	CUI E3 C0007820
A6	UMLS-Preferred-Name E3 Cerebrovascular Disorders
A7	MEDDRA-PT E3 Cerebrovascular disorder
A8	MEDDRA-PT-ID E3 10008196
A9	CUI E4 C0038454
A10	UMLS-Preferred-Name E4 Cerebrovascular accident
A11	MEDDRA-PT E4 Cerebrovascular accident
A12	MEDDRA-PT-ID E4 10008190
A13	LLT E4 Stroke
A14	LLT-ID E4 10042244
A15	CUI E5 C0151878
A16	UMLS-Preferred-Name E5 Prolonged QT interval
A17	MEDDRA-PT E5 Electrocardiogram QT prolonged
A18	MEDDRA-PT-ID E5 10014387
A19	LLT E5 QT prolonged
A20	LLT-ID E5 10037705
A21	CUI E6 C0151878
A22	UMLS-Preferred-Name E6 Prolonged QT interval
A23	MEDDRA-PT E6 Electrocardiogram QT prolonged
A24	MEDDRA-PT-ID E6 10014387
A25	LLT E6 QT interval prolonged
A26	LLT-ID E6 10037703
A27	CUI E7 C0003811
A28	UMLS-Preferred-Name E7 Cardiac Arrhythmia
A29	MEDDRA-PT E7 Arrhythmia
A30	MEDDRA-PT-ID E7 10003119
A31	CUI E9 C0011071
A32	UMLS-Preferred-Name E9 Sudden death
A33	MEDDRA-PT E9 Sudden death
A34	MEDDRA-PT-ID E9 10042434
A35	CUI E10 C0027849
A36	UMLS-Preferred-Name E10 Neuroleptic Malignant Syndrome
A37	MEDDRA-PT E10 Neuroleptic malignant syndrome
A38	MEDDRA-PT-ID E10 10029282
A39	CUI E11 C0686347
A40	UMLS-Preferred-Name E11 Tardive Dyskinesia
A41	MEDDRA-PT E11 Tardive dyskinesia
A42	MEDDRA-PT-ID E11 10043118
A43	CUI E12 C0020456
A44	UMLS-Preferred-Name E12 Hyperglycemia
A45	MEDDRA-PT E12 Hyperglycaemia
A46	MEDDRA-PT-ID E12 10020635
A47	LLT E12 Hyperglycemia
A48	LLT-ID E12 10020639
A49	CUI E13 C0011849
A50	UMLS-Preferred-Name E13 Diabetes Mellitus
A51	MEDDRA-PT E13 Diabetes mellitus
A52	MEDDRA-PT-ID E13 10012601
A53	CUI E14 C0242339
A54	UMLS-Preferred-Name E14 Dyslipidemias
A55	MEDDRA-PT E14 Dyslipidaemia
A56	MEDDRA-PT-ID E14 10058108
A57	LLT E14 Dyslipidemia
A58	LLT-ID E14 10058110
A59	CUI E15 C0043094
A60	UMLS-Preferred-Name E15 Weight Gain
A61	MEDDRA-PT E15 Weight increased
A62	MEDDRA-PT-ID E15 10047899
A63	LLT E15 Weight gain
A64	LLT-ID E15 10047896
A65	CUI E17 C0850624
A66	UMLS-Preferred-Name E17 cardiovascular risk factor
A67	MEDDRA-PT E17 Cardiovascular symptom
A68	MEDDRA-PT-ID E17 10075534
A69	CUI E18 C0007820
A70	UMLS-Preferred-Name E18 Cerebrovascular Disorders
A71	MEDDRA-PT E18 Cerebrovascular disorder
A72	MEDDRA-PT-ID E18 10008196
A73	CUI E19 C0020456
A74	UMLS-Preferred-Name E19 Hyperglycemia
A75	MEDDRA-PT E19 Hyperglycaemia
A76	MEDDRA-PT-ID E19 10020635
A77	LLT E19 Hyperglycemia
A78	LLT-ID E19 10020639
A79	CUI E20 C0242339
A80	UMLS-Preferred-Name E20 Dyslipidemias
A81	MEDDRA-PT E20 Dyslipidaemia
A82	MEDDRA-PT-ID E20 10058108
A83	LLT E20 Dyslipidemia
A84	LLT-ID E20 10058110
A85	CUI E21 C0043094
A86	UMLS-Preferred-Name E21 Weight Gain
A87	MEDDRA-PT E21 Weight increased
A88	MEDDRA-PT-ID E21 10047899
A89	LLT E21 Weight gain
A90	LLT-ID E21 10047896
A91	CUI E22 C0036572
A92	UMLS-Preferred-Name E22 Seizures
A93	MEDDRA-PT E22 Seizure
A94	MEDDRA-PT-ID E22 10039906
A95	LLT E22 Seizures
A96	LLT-ID E22 10039910
A97	CUI E23 C0020651
A98	UMLS-Preferred-Name E23 Hypotension, Orthostatic
A99	MEDDRA-PT E23 Orthostatic hypotension
A100	MEDDRA-PT-ID E23 10031127
A101	CUI E24 C0023530
A102	UMLS-Preferred-Name E24 Leukopenia
A103	MEDDRA-PT E24 Leukopenia
A104	MEDDRA-PT-ID E24 10024384
A105	CUI E25 C0027947
A106	UMLS-Preferred-Name E25 Neutropenia
A107	MEDDRA-PT E25 Neutropenia
A108	MEDDRA-PT-ID E25 10029354
A109	CUI E26 C0001824
A110	UMLS-Preferred-Name E26 Agranulocytosis
A111	MEDDRA-PT E26 Agranulocytosis
A112	MEDDRA-PT-ID E26 10001507
A113	CUI E27 C0038661
A114	UMLS-Preferred-Name E27 Suicide
A115	MEDDRA-PT E27 Completed suicide
A116	MEDDRA-PT-ID E27 10010144
A117	LLT E27 Suicide
A118	LLT-ID E27 10042462
A119	CUI E28 C0033117
A120	UMLS-Preferred-Name E28 Priapism
A121	MEDDRA-PT E28 Priapism
A122	MEDDRA-PT-ID E28 10036661
A123	CUI E29 C0338656
A124	UMLS-Preferred-Name E29 Impaired cognition
A125	MEDDRA-PT E29 Cognitive disorder
A126	MEDDRA-PT-ID E29 10057668
A127	LLT E29 Cognitive impairment
A128	LLT-ID E29 10009846
A129	CUI E30 C0221163
A130	UMLS-Preferred-Name E30 Motor Disorders
A131	MEDDRA-PT E30 Motor dysfunction
A132	MEDDRA-PT-ID E30 10061296
A133	CUI E34 C1306577
A134	UMLS-Preferred-Name E34 Death (finding)
A135	MEDDRA-PT E34 Death
A136	MEDDRA-PT-ID E34 10011906
A137	CUI E35 C0007820
A138	UMLS-Preferred-Name E35 Cerebrovascular Disorders
A139	MEDDRA-PT E35 Cerebrovascular disorder
A140	MEDDRA-PT-ID E35 10008196
A141	CUI E36 C0038454
A142	UMLS-Preferred-Name E36 Cerebrovascular accident
A143	MEDDRA-PT E36 Cerebrovascular accident
A144	MEDDRA-PT-ID E36 10008190
A145	CUI E37 C0007787
A146	UMLS-Preferred-Name E37 Transient Ischemic Attack
A147	MEDDRA-PT E37 Transient ischaemic attack
A148	MEDDRA-PT-ID E37 10044390
A149	LLT E37 Transient ischemic attacks
A150	LLT-ID E37 10044391
A151	CUI E38 C1306577
A152	UMLS-Preferred-Name E38 Death (finding)
A153	MEDDRA-PT E38 Death
A154	MEDDRA-PT-ID E38 10011906
A155	CUI E39 C0855333
A156	UMLS-Preferred-Name E39 Electrocardiogram QT corrected interval prolonged
A157	MEDDRA-PT E39 Electrocardiogram QT prolonged
A158	MEDDRA-PT-ID E39 10014387
A159	LLT E39 Electrocardiogram QTc interval prolonged
A160	LLT-ID E39 10053698
A161	CUI E41 C3828431
A162	UMLS-Preferred-Name E41 QTcF Prolongation
A163	MEDDRA-PT E41 Electrocardiogram QT prolonged
A164	MEDDRA-PT-ID E41 10014387
A165	LLT E41 Electrocardiogram QTc interval prolonged
A166	LLT-ID E41 10053698
A167	CUI E43 C0040479
A168	UMLS-Preferred-Name E43 Torsades de Pointes
A169	MEDDRA-PT E43 Torsade de pointes
A170	MEDDRA-PT-ID E43 10044066
A171	CUI E45 C0003811
A172	UMLS-Preferred-Name E45 Cardiac Arrhythmia
A173	MEDDRA-PT E45 Arrhythmia
A174	MEDDRA-PT-ID E45 10003119
A175	LLT E45 Cardiac arrhythmia
A176	LLT-ID E45 10007518
A177	CUI E53 C0027849
A178	UMLS-Preferred-Name E53 Neuroleptic Malignant Syndrome
A179	MEDDRA-PT E53 Neuroleptic malignant syndrome
A180	MEDDRA-PT-ID E53 10029282
A181	CUI E54 C0027849
A182	UMLS-Preferred-Name E54 Neuroleptic Malignant Syndrome
A183	MEDDRA-PT E54 Neuroleptic malignant syndrome
A184	MEDDRA-PT-ID E54 10029282
A185	LLT E54 NMS
A186	LLT-ID E54 10029435
A187	CUI E55 C0392676
A188	UMLS-Preferred-Name E55 Hyperpyrexia
A189	MEDDRA-PT E55 Hyperpyrexia
A190	MEDDRA-PT-ID E55 10020741
A191	CUI E56 C0026837
A192	UMLS-Preferred-Name E56 Muscle Rigidity
A193	MEDDRA-PT E56 Muscle rigidity
A194	MEDDRA-PT-ID E56 10028330
A195	CUI E57 C0856054
A196	UMLS-Preferred-Name E57 Mental status changes
A197	MEDDRA-PT E57 Mental status changes
A198	MEDDRA-PT-ID E57 10048294
A199	CUI E58 C3251821
A200	UMLS-Preferred-Name E58 Catatonic reaction
A201	MEDDRA-PT E58 Catatonia
A202	MEDDRA-PT-ID E58 10007776
A203	LLT E58 Reaction catatonic
A204	LLT-ID E58 10037940
A205	CUI E59 C0262385
A206	UMLS-Preferred-Name E59 Autonomic nervous system imbalance
A207	MEDDRA-PT E59 Autonomic nervous system imbalance
A208	MEDDRA-PT-ID E59 10003840
A209	LLT E59 Autonomic instability
A210	LLT-ID E59 10049218
A211	CUI E60 C0392684
A212	UMLS-Preferred-Name E60 Pulse irregular
A213	MEDDRA-PT E60 Heart rate irregular
A214	MEDDRA-PT-ID E60 10019304
A215	LLT E60 Irregular pulse
A216	LLT-ID E60 10022994
A217	CUI E61 C0549405
A218	UMLS-Preferred-Name E61 Blood pressure fluctuation
A219	MEDDRA-PT E61 Blood pressure fluctuation
A220	MEDDRA-PT-ID E61 10005746
A221	CUI E62 C0039231
A222	UMLS-Preferred-Name E62 Tachycardia
A223	MEDDRA-PT E62 Tachycardia
A224	MEDDRA-PT-ID E62 10043071
A225	CUI E63 C0700590
A226	UMLS-Preferred-Name E63 Increased sweating
A227	MEDDRA-PT E63 Hyperhidrosis
A228	MEDDRA-PT-ID E63 10020642
A229	LLT E63 Diaphoresis
A230	LLT-ID E63 10012703
A231	CUI E64 C0003811
A232	UMLS-Preferred-Name E64 Cardiac Arrhythmia
A233	MEDDRA-PT E64 Arrhythmia
A234	MEDDRA-PT-ID E64 10003119
A235	LLT E64 Cardiac dysrhythmias
A236	LLT-ID E64 10007545
A237	CUI E65 C0151576
A238	UMLS-Preferred-Name E65 Elevated creatine kinase
A239	MEDDRA-PT E65 Blood creatine phosphokinase increased
A240	MEDDRA-PT-ID E65 10005470
A241	LLT E65 Creatine phosphokinase increased
A242	LLT-ID E65 10011349
A243	CUI E66 C0027080
A244	UMLS-Preferred-Name E66 Myoglobinuria
A245	MEDDRA-PT E66 Myoglobinuria
A246	MEDDRA-PT-ID E66 10028629
A247	CUI E67 C0035410
A248	UMLS-Preferred-Name E67 Rhabdomyolysis
A249	MEDDRA-PT E67 Rhabdomyolysis
A250	MEDDRA-PT-ID E67 10039020
A251	CUI E68 C0022660
A252	UMLS-Preferred-Name E68 Kidney Failure, Acute
A253	MEDDRA-PT E68 Acute kidney injury
A254	MEDDRA-PT-ID E68 10069339
A255	LLT E68 Acute renal failure
A256	LLT-ID E68 10001041
A257	CUI E69 C0686347
A258	UMLS-Preferred-Name E69 Tardive Dyskinesia
A259	MEDDRA-PT E69 Tardive dyskinesia
A260	MEDDRA-PT-ID E69 10043118
A261	CUI E71 C0427086
A262	UMLS-Preferred-Name E71 Involuntary Movements
A263	MEDDRA-PT E71 Dyskinesia
A264	MEDDRA-PT-ID E71 10013916
A265	LLT E71 Movements involuntary
A266	LLT-ID E71 10028041
A267	flag E80 unmapped
A268	CUI E80 C0850624
A269	UMLS-Preferred-Name E80 cardiovascular risk factor
A270	flag E82 unmapped
A271	CUI E83 C0020456
A272	UMLS-Preferred-Name E83 Hyperglycemia
A273	MEDDRA-PT E83 Hyperglycaemia
A274	MEDDRA-PT-ID E83 10020635
A275	LLT E83 Hyperglycemia
A276	LLT-ID E83 10020639
A277	CUI E84 C0242339
A278	UMLS-Preferred-Name E84 Dyslipidemias
A279	MEDDRA-PT E84 Dyslipidaemia
A280	MEDDRA-PT-ID E84 10058108
A281	LLT E84 Dyslipidemia
A282	LLT-ID E84 10058110
A283	CUI E85 C0043094
A284	UMLS-Preferred-Name E85 Weight Gain
A285	MEDDRA-PT E85 Weight increased
A286	MEDDRA-PT-ID E85 10047899
A287	LLT E85 Weight gain
A288	LLT-ID E85 10047896
A289	CUI E86 C0020456
A290	UMLS-Preferred-Name E86 Hyperglycemia
A291	MEDDRA-PT E86 Hyperglycaemia
A292	MEDDRA-PT-ID E86 10020635
A293	LLT E86 Hyperglycemia
A294	LLT-ID E86 10020639
A295	CUI E87 C0220982
A296	UMLS-Preferred-Name E87 Ketoacidosis
A297	MEDDRA-PT E87 Ketoacidosis
A298	MEDDRA-PT-ID E87 10023379
A299	flag E89 duplicate
A300	CUI E89 C0020457
A301	UMLS-Preferred-Name E89 Hyperglycemic Hyperosmolar Nonketotic Coma
A302	MEDDRA-PT E89 Hyperosmolar state
A303	MEDDRA-PT-ID E89 10020697
A304	CUI E90 C1306577
A305	UMLS-Preferred-Name E90 Death (finding)
A306	MEDDRA-PT E90 Death
A307	MEDDRA-PT-ID E90 10011906
A308	CUI E92 C0020456
A309	UMLS-Preferred-Name E92 Hyperglycemia
A310	MEDDRA-PT E92 Hyperglycaemia
A311	MEDDRA-PT-ID E92 10020635
A312	LLT E92 Hyperglycemia
A313	LLT-ID E92 10020639
A314	CUI E94 C0549634
A315	UMLS-Preferred-Name E94 Lipids abnormal
A316	MEDDRA-PT E94 Lipids abnormal
A317	MEDDRA-PT-ID E94 10024588
A318	CUI E95 C0043094
A319	UMLS-Preferred-Name E95 Weight Gain
A320	MEDDRA-PT E95 Weight increased
A321	MEDDRA-PT-ID E95 10047899
A322	LLT E95 Weight gain
A323	LLT-ID E95 10047896
A324	CUI E101 C0036572
A325	UMLS-Preferred-Name E101 Seizures
A326	MEDDRA-PT E101 Seizure
A327	MEDDRA-PT-ID E101 10039906
A328	LLT E101 Seizures
A329	LLT-ID E101 10039910
A330	CUI E102 C0020651
A331	UMLS-Preferred-Name E102 Hypotension, Orthostatic
A332	MEDDRA-PT E102 Orthostatic hypotension
A333	MEDDRA-PT-ID E102 10031127
A334	CUI E104 C0012833
A335	UMLS-Preferred-Name E104 Dizziness
A336	MEDDRA-PT E104 Dizziness
A337	MEDDRA-PT-ID E104 10013573
A338	CUI E105 C0039231
A339	UMLS-Preferred-Name E105 Tachycardia
A340	MEDDRA-PT E105 Tachycardia
A341	MEDDRA-PT-ID E105 10043071
A342	CUI E106 C0039070
A343	UMLS-Preferred-Name E106 Syncope
A344	MEDDRA-PT E106 Syncope
A345	MEDDRA-PT-ID E106 10042772
A346	CUI E107 C0039070
A347	UMLS-Preferred-Name E107 Syncope
A348	MEDDRA-PT E107 Syncope
A349	MEDDRA-PT-ID E107 10042772
A350	CUI E108 C0020651
A351	UMLS-Preferred-Name E108 Hypotension, Orthostatic
A352	MEDDRA-PT E108 Orthostatic hypotension
A353	MEDDRA-PT-ID E108 10031127
A354	CUI E109 C0023530
A355	UMLS-Preferred-Name E109 Leukopenia
A356	MEDDRA-PT E109 Leukopenia
A357	MEDDRA-PT-ID E109 10024384
A358	CUI E110 C0027947
A359	UMLS-Preferred-Name E110 Neutropenia
A360	MEDDRA-PT E110 Neutropenia
A361	MEDDRA-PT-ID E110 10029354
A362	CUI E111 C0001824
A363	UMLS-Preferred-Name E111 Agranulocytosis
A364	MEDDRA-PT E111 Agranulocytosis
A365	MEDDRA-PT-ID E111 10001507
A366	CUI E112 C0023530
A367	UMLS-Preferred-Name E112 Leukopenia
A368	MEDDRA-PT E112 Leukopenia
A369	MEDDRA-PT-ID E112 10024384
A370	CUI E113 C0027947
A371	UMLS-Preferred-Name E113 Neutropenia
A372	MEDDRA-PT E113 Neutropenia
A373	MEDDRA-PT-ID E113 10029354
A374	CUI E114 C0747979
A375	UMLS-Preferred-Name E114 Increased prolactin level
A376	MEDDRA-PT E114 Blood prolactin increased
A377	MEDDRA-PT-ID E114 10005780
A378	LLT E114 Prolactin levels increased
A379	LLT-ID E114 10036828
A380	CUI E115 C0020514
A381	UMLS-Preferred-Name E115 Hyperprolactinemia
A382	MEDDRA-PT E115 Hyperprolactinaemia
A383	MEDDRA-PT-ID E115 10020737
A384	LLT E115 Hyperprolactinemia
A385	LLT-ID E115 10020739
A386	CUI E116 C1558153
A387	UMLS-Preferred-Name E116 Adverse Event Associated with Sexual and Reproductive Function
A388	MEDDRA-PT E116 Reproductive toxicity
A389	MEDDRA-PT-ID E116 10074268
A390	CUI E117 C3665358
A391	UMLS-Preferred-Name E117 Galactorrhea
A392	MEDDRA-PT E117 Galactorrhoea
A393	MEDDRA-PT-ID E117 10017600
A394	LLT E117 Galactorrhea
A395	LLT-ID E117 10017592
A396	CUI E118 C0002453
A397	UMLS-Preferred-Name E118 Amenorrhea
A398	MEDDRA-PT E118 Amenorrhoea
A399	MEDDRA-PT-ID E118 10001928
A400	LLT E118 Amenorrhea
A401	LLT-ID E118 10001927
A402	CUI E119 C0018418
A403	UMLS-Preferred-Name E119 Gynecomastia
A404	MEDDRA-PT E119 Gynaecomastia
A405	MEDDRA-PT-ID E119 10018800
A406	LLT E119 Gynecomastia
A407	LLT-ID E119 10018801
A408	CUI E120 C0242350
A409	UMLS-Preferred-Name E120 Erectile dysfunction
A410	MEDDRA-PT E120 Erectile dysfunction
A411	MEDDRA-PT-ID E120 10061461
A412	LLT E120 Impotence
A413	LLT-ID E120 10021550
A414	CUI E121 C0020514
A415	UMLS-Preferred-Name E121 Hyperprolactinemia
A416	MEDDRA-PT E121 Hyperprolactinaemia
A417	MEDDRA-PT-ID E121 10020737
A418	LLT E121 Hyperprolactinemia
A419	LLT-ID E121 10020739
A420	CUI E123 C0877225
A421	UMLS-Preferred-Name E123 Bone density decreased
A422	MEDDRA-PT E123 Bone density decreased
A423	MEDDRA-PT-ID E123 10049470
A424	CUI E124 C0857980
A425	UMLS-Preferred-Name E124 Serum prolactin increased
A426	MEDDRA-PT E124 Blood prolactin increased
A427	MEDDRA-PT-ID E124 10005780
A428	LLT E124 Serum prolactin increased
A429	LLT-ID E124 10040384
A430	flag E125 underspecified
A431	CUI E125 C0740306
A432	UMLS-Preferred-Name E125 Biopsy breast abnormal
A433	MEDDRA-PT E125 Biopsy breast abnormal
A434	MEDDRA-PT-ID E125 10004745
A435	CUI E128 C0857716
A436	UMLS-Preferred-Name E128 Plasma prolactin increased
A437	MEDDRA-PT E128 Blood prolactin increased
A438	MEDDRA-PT-ID E128 10005780
A439	LLT E128 Plasma prolactin increased
A440	LLT-ID E128 10035415
A441	CUI E129 C0857716
A442	UMLS-Preferred-Name E129 Plasma prolactin increased
A443	MEDDRA-PT E129 Blood prolactin increased
A444	MEDDRA-PT-ID E129 10005780
A445	LLT E129 Plasma prolactin increased
A446	LLT-ID E129 10035415
A447	CUI E131 C0553731
A448	UMLS-Preferred-Name E131 PRL increased
A449	MEDDRA-PT E131 Blood prolactin increased
A450	MEDDRA-PT-ID E131 10005780
A451	LLT E131 Prolactin increased
A452	LLT-ID E131 10036826
A453	CUI E132 C0018418
A454	UMLS-Preferred-Name E132 Gynecomastia
A455	MEDDRA-PT E132 Gynaecomastia
A456	MEDDRA-PT-ID E132 10018800
A457	LLT E132 Gynecomastia
A458	LLT-ID E132 10018801
A459	CUI E133 C3665358
A460	UMLS-Preferred-Name E133 Galactorrhea
A461	MEDDRA-PT E133 Galactorrhoea
A462	MEDDRA-PT-ID E133 10017600
A463	LLT E133 Galactorrhea
A464	LLT-ID E133 10017592
A465	CUI E134 C0854171
A466	UMLS-Preferred-Name E134 Temperature regulation disorder
A467	MEDDRA-PT E134 Temperature regulation disorder
A468	MEDDRA-PT-ID E134 10061376
A469	CUI E136 C0014858
A470	UMLS-Preferred-Name E136 Esophageal motility disorders
A471	MEDDRA-PT E136 Oesophageal motility disorder
A472	MEDDRA-PT-ID E136 10072419
A473	LLT E136 Esophageal motility disorder
A474	LLT-ID E136 10072420
A475	CUI E137 C0700198
A476	UMLS-Preferred-Name E137 Pulmonary aspiration
A477	MEDDRA-PT E137 Aspiration
A478	MEDDRA-PT-ID E137 10003504
A479	CUI E140 C0033117
A480	UMLS-Preferred-Name E140 Priapism
A481	MEDDRA-PT E140 Priapism
A482	MEDDRA-PT-ID E140 10036661
A483	CUI E142 C0033117
A484	UMLS-Preferred-Name E142 Priapism
A485	MEDDRA-PT E142 Priapism
A486	MEDDRA-PT-ID E142 10036661
A487	CUI E143 C0033117
A488	UMLS-Preferred-Name E143 Priapism
A489	MEDDRA-PT E143 Priapism
A490	MEDDRA-PT-ID E143 10036661
A491	CUI E145 C0233818
A492	UMLS-Preferred-Name E145 Impaired judgement
A493	MEDDRA-PT E145 Judgement impaired
A494	MEDDRA-PT-ID E145 10023236
A495	CUI E146 C0233632
A496	UMLS-Preferred-Name E146 Disturbance in thinking
A497	MEDDRA-PT E146 Thinking abnormal
A498	MEDDRA-PT-ID E146 10043431
A499	CUI E147 C1963825
A500	UMLS-Preferred-Name E147 Reduced dexterity
A501	MEDDRA-PT E147 Motor dysfunction
A502	MEDDRA-PT-ID E147 10061296
A503	CUI E148 C2830004
A504	UMLS-Preferred-Name E148 Somnolence
A505	MEDDRA-PT E148 Somnolence
A506	MEDDRA-PT-ID E148 10041349
A507	CUI E149 C0235195
A508	UMLS-Preferred-Name E149 Sedated state
A509	MEDDRA-PT E149 Sedation
A510	MEDDRA-PT-ID E149 10039897
A511	CUI E152 C0012833
A512	UMLS-Preferred-Name E152 Dizziness
A513	MEDDRA-PT E152 Dizziness
A514	MEDDRA-PT-ID E152 10013573
A515	CUI E153 C0039231
A516	UMLS-Preferred-Name E153 Tachycardia
A517	MEDDRA-PT E153 Tachycardia
A518	MEDDRA-PT-ID E153 10043071
A519	CUI E154 C0039070
A520	UMLS-Preferred-Name E154 Syncope
A521	MEDDRA-PT E154 Syncope
A522	MEDDRA-PT-ID E154 10042772
A523	CUI E73 C0043094
A524	UMLS-Preferred-Name E73 Weight Gain
A525	MEDDRA-PT E73 Weight increased
A526	MEDDRA-PT-ID E73 10047899
A527	LLT E73 Weight gain
A528	LLT-ID E73 10047896
A529	CUI E75 C1306577
A530	UMLS-Preferred-Name E75 Death (finding)
A531	MEDDRA-PT E75 Death
A532	MEDDRA-PT-ID E75 10011906
A533	CUI E76 C0151676
A534	UMLS-Preferred-Name E76 Pituitary gonadotrophin decreased
A535	MEDDRA-PT E76 Blood gonadotrophin decreased
A536	MEDDRA-PT-ID E76 10005562
A537	LLT E76 Pituitary gonadotrophin decreased
A538	LLT-ID E76 10054718
A539	CUI E77 C4025644
A540	UMLS-Preferred-Name E77 Hypothalamic gonadotropin-releasing hormone (GNRH) deficiency
A541	MEDDRA-PT E77 Blood gonadotrophin decreased
A542	MEDDRA-PT-ID E77 10005562
A543	LLT E77 Gonadotropins decreased
A544	LLT-ID E77 10018546
A545	CUI E91 C0020619
A546	UMLS-Preferred-Name E91 Hypogonadism
A547	MEDDRA-PT E91 Hypogonadism
A548	MEDDRA-PT-ID E91 10058359
A549	CUI E98 C0553731
A550	UMLS-Preferred-Name E98 PRL increased
A551	MEDDRA-PT E98 Blood prolactin increased
A552	MEDDRA-PT-ID E98 10005780
A553	LLT E98 Prolactin increased
A554	LLT-ID E98 10036826
A555	flag E42 underspecified
A556	CUI E42 C2242620
A557	UMLS-Preferred-Name E42 Gonadal insufficiency
A558	MEDDRA-PT E42 Hypogonadism
A559	MEDDRA-PT-ID E42 10058359
A560	LLT E42 Gonadal insufficiency
A561	LLT-ID E42 10068037
A562	CUI E81 C0025517
A563	UMLS-Preferred-Name E81 Metabolic Diseases
A564	MEDDRA-PT E81 Metabolic disorder
A565	MEDDRA-PT-ID E81 10058097
A566	CUI E157 C0025517
A567	UMLS-Preferred-Name E157 Metabolic Diseases
A568	MEDDRA-PT E157 Metabolic disorder
A569	MEDDRA-PT-ID E157 10058097
